589 related articles for article (PubMed ID: 26814967)
1. Active medulloblastoma enhancers reveal subgroup-specific cellular origins.
Lin CY; Erkek S; Tong Y; Yin L; Federation AJ; Zapatka M; Haldipur P; Kawauchi D; Risch T; Warnatz HJ; Worst BC; Ju B; Orr BA; Zeid R; Polaski DR; Segura-Wang M; Waszak SM; Jones DT; Kool M; Hovestadt V; Buchhalter I; Sieber L; Johann P; Chavez L; Gröschel S; Ryzhova M; Korshunov A; Chen W; Chizhikov VV; Millen KJ; Amstislavskiy V; Lehrach H; Yaspo ML; Eils R; Lichter P; Korbel JO; Pfister SM; Bradner JE; Northcott PA
Nature; 2016 Feb; 530(7588):57-62. PubMed ID: 26814967
[TBL] [Abstract][Full Text] [Related]
2. OTX2 Activity at Distal Regulatory Elements Shapes the Chromatin Landscape of Group 3 Medulloblastoma.
Boulay G; Awad ME; Riggi N; Archer TC; Iyer S; Boonseng WE; Rossetti NE; Naigles B; Rengarajan S; Volorio A; Kim JC; Mesirov JP; Tamayo P; Pomeroy SL; Aryee MJ; Rivera MN
Cancer Discov; 2017 Mar; 7(3):288-301. PubMed ID: 28213356
[TBL] [Abstract][Full Text] [Related]
3. Dissecting the genomic complexity underlying medulloblastoma.
Jones DT; Jäger N; Kool M; Zichner T; Hutter B; Sultan M; Cho YJ; Pugh TJ; Hovestadt V; Stütz AM; Rausch T; Warnatz HJ; Ryzhova M; Bender S; Sturm D; Pleier S; Cin H; Pfaff E; Sieber L; Wittmann A; Remke M; Witt H; Hutter S; Tzaridis T; Weischenfeldt J; Raeder B; Avci M; Amstislavskiy V; Zapatka M; Weber UD; Wang Q; Lasitschka B; Bartholomae CC; Schmidt M; von Kalle C; Ast V; Lawerenz C; Eils J; Kabbe R; Benes V; van Sluis P; Koster J; Volckmann R; Shih D; Betts MJ; Russell RB; Coco S; Tonini GP; Schüller U; Hans V; Graf N; Kim YJ; Monoranu C; Roggendorf W; Unterberg A; Herold-Mende C; Milde T; Kulozik AE; von Deimling A; Witt O; Maass E; Rössler J; Ebinger M; Schuhmann MU; Frühwald MC; Hasselblatt M; Jabado N; Rutkowski S; von Bueren AO; Williamson D; Clifford SC; McCabe MG; Collins VP; Wolf S; Wiemann S; Lehrach H; Brors B; Scheurlen W; Felsberg J; Reifenberger G; Northcott PA; Taylor MD; Meyerson M; Pomeroy SL; Yaspo ML; Korbel JO; Korshunov A; Eils R; Pfister SM; Lichter P
Nature; 2012 Aug; 488(7409):100-5. PubMed ID: 22832583
[TBL] [Abstract][Full Text] [Related]
4. Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencing.
Hovestadt V; Jones DT; Picelli S; Wang W; Kool M; Northcott PA; Sultan M; Stachurski K; Ryzhova M; Warnatz HJ; Ralser M; Brun S; Bunt J; Jäger N; Kleinheinz K; Erkek S; Weber UD; Bartholomae CC; von Kalle C; Lawerenz C; Eils J; Koster J; Versteeg R; Milde T; Witt O; Schmidt S; Wolf S; Pietsch T; Rutkowski S; Scheurlen W; Taylor MD; Brors B; Felsberg J; Reifenberger G; Borkhardt A; Lehrach H; Wechsler-Reya RJ; Eils R; Yaspo ML; Landgraf P; Korshunov A; Zapatka M; Radlwimmer B; Pfister SM; Lichter P
Nature; 2014 Jun; 510(7506):537-41. PubMed ID: 24847876
[TBL] [Abstract][Full Text] [Related]
5. The RNA-binding protein Musashi1 affects medulloblastoma growth via a network of cancer-related genes and is an indicator of poor prognosis.
Vo DT; Subramaniam D; Remke M; Burton TL; Uren PJ; Gelfond JA; de Sousa Abreu R; Burns SC; Qiao M; Suresh U; Korshunov A; Dubuc AM; Northcott PA; Smith AD; Pfister SM; Taylor MD; Janga SC; Anant S; Vogel C; Penalva LO
Am J Pathol; 2012 Nov; 181(5):1762-72. PubMed ID: 22985791
[TBL] [Abstract][Full Text] [Related]
6. Novel mutations target distinct subgroups of medulloblastoma.
Robinson G; Parker M; Kranenburg TA; Lu C; Chen X; Ding L; Phoenix TN; Hedlund E; Wei L; Zhu X; Chalhoub N; Baker SJ; Huether R; Kriwacki R; Curley N; Thiruvenkatam R; Wang J; Wu G; Rusch M; Hong X; Becksfort J; Gupta P; Ma J; Easton J; Vadodaria B; Onar-Thomas A; Lin T; Li S; Pounds S; Paugh S; Zhao D; Kawauchi D; Roussel MF; Finkelstein D; Ellison DW; Lau CC; Bouffet E; Hassall T; Gururangan S; Cohn R; Fulton RS; Fulton LL; Dooling DJ; Ochoa K; Gajjar A; Mardis ER; Wilson RK; Downing JR; Zhang J; Gilbertson RJ
Nature; 2012 Aug; 488(7409):43-8. PubMed ID: 22722829
[TBL] [Abstract][Full Text] [Related]
7. Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes.
Sharma T; Schwalbe EC; Williamson D; Sill M; Hovestadt V; Mynarek M; Rutkowski S; Robinson GW; Gajjar A; Cavalli F; Ramaswamy V; Taylor MD; Lindsey JC; Hill RM; Jäger N; Korshunov A; Hicks D; Bailey S; Kool M; Chavez L; Northcott PA; Pfister SM; Clifford SC
Acta Neuropathol; 2019 Aug; 138(2):309-326. PubMed ID: 31076851
[TBL] [Abstract][Full Text] [Related]
8. Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples.
Northcott PA; Shih DJ; Remke M; Cho YJ; Kool M; Hawkins C; Eberhart CG; Dubuc A; Guettouche T; Cardentey Y; Bouffet E; Pomeroy SL; Marra M; Malkin D; Rutka JT; Korshunov A; Pfister S; Taylor MD
Acta Neuropathol; 2012 Apr; 123(4):615-26. PubMed ID: 22057785
[TBL] [Abstract][Full Text] [Related]
9. Gene expression analyses of the spatio-temporal relationships of human medulloblastoma subgroups during early human neurogenesis.
Hooper CM; Hawes SM; Kees UR; Gottardo NG; Dallas PB
PLoS One; 2014; 9(11):e112909. PubMed ID: 25412507
[TBL] [Abstract][Full Text] [Related]
10. Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma.
Northcott PA; Lee C; Zichner T; Stütz AM; Erkek S; Kawauchi D; Shih DJ; Hovestadt V; Zapatka M; Sturm D; Jones DT; Kool M; Remke M; Cavalli FM; Zuyderduyn S; Bader GD; VandenBerg S; Esparza LA; Ryzhova M; Wang W; Wittmann A; Stark S; Sieber L; Seker-Cin H; Linke L; Kratochwil F; Jäger N; Buchhalter I; Imbusch CD; Zipprich G; Raeder B; Schmidt S; Diessl N; Wolf S; Wiemann S; Brors B; Lawerenz C; Eils J; Warnatz HJ; Risch T; Yaspo ML; Weber UD; Bartholomae CC; von Kalle C; Turányi E; Hauser P; Sanden E; Darabi A; Siesjö P; Sterba J; Zitterbart K; Sumerauer D; van Sluis P; Versteeg R; Volckmann R; Koster J; Schuhmann MU; Ebinger M; Grimes HL; Robinson GW; Gajjar A; Mynarek M; von Hoff K; Rutkowski S; Pietsch T; Scheurlen W; Felsberg J; Reifenberger G; Kulozik AE; von Deimling A; Witt O; Eils R; Gilbertson RJ; Korshunov A; Taylor MD; Lichter P; Korbel JO; Wechsler-Reya RJ; Pfister SM
Nature; 2014 Jul; 511(7510):428-34. PubMed ID: 25043047
[TBL] [Abstract][Full Text] [Related]
11. Chromatin accessibility mapping identifies mediators of basal transcription and retinoid-induced repression of OTX2 in medulloblastoma.
Wortham M; Guo C; Zhang M; Song L; Lee BK; Iyer VR; Furey TS; Crawford GE; Yan H; He Y
PLoS One; 2014; 9(9):e107156. PubMed ID: 25198066
[TBL] [Abstract][Full Text] [Related]
12. [Subtypes of medulloblastomas: distinct cellular origins].
Bourdeaut F; Pouponnot C; Ayrault O
Med Sci (Paris); 2012 Oct; 28(10):805-9. PubMed ID: 23067406
[No Abstract] [Full Text] [Related]
13. Dissecting super-enhancer driven transcriptional dependencies reveals novel therapeutic strategies and targets for group 3 subtype medulloblastoma.
Li M; Han Y; Wang C; Kang W; Jiang W; Zhang L; Tang Y
J Exp Clin Cancer Res; 2022 Oct; 41(1):311. PubMed ID: 36273157
[TBL] [Abstract][Full Text] [Related]
14. Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome.
Cho YJ; Tsherniak A; Tamayo P; Santagata S; Ligon A; Greulich H; Berhoukim R; Amani V; Goumnerova L; Eberhart CG; Lau CC; Olson JM; Gilbertson RJ; Gajjar A; Delattre O; Kool M; Ligon K; Meyerson M; Mesirov JP; Pomeroy SL
J Clin Oncol; 2011 Apr; 29(11):1424-30. PubMed ID: 21098324
[TBL] [Abstract][Full Text] [Related]
15. Medulloblastoma subgroups remain stable across primary and metastatic compartments.
Wang X; Dubuc AM; Ramaswamy V; Mack S; Gendoo DM; Remke M; Wu X; Garzia L; Luu B; Cavalli F; Peacock J; López B; Skowron P; Zagzag D; Lyden D; Hoffman C; Cho YJ; Eberhart C; MacDonald T; Li XN; Van Meter T; Northcott PA; Haibe-Kains B; Hawkins C; Rutka JT; Bouffet E; Pfister SM; Korshunov A; Taylor MD
Acta Neuropathol; 2015 Mar; 129(3):449-57. PubMed ID: 25689980
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic regulation in medulloblastoma.
Yi J; Wu J
Mol Cell Neurosci; 2018 Mar; 87():65-76. PubMed ID: 29269116
[TBL] [Abstract][Full Text] [Related]
17. Childhood cerebellar tumours mirror conserved fetal transcriptional programs.
Vladoiu MC; El-Hamamy I; Donovan LK; Farooq H; Holgado BL; Sundaravadanam Y; Ramaswamy V; Hendrikse LD; Kumar S; Mack SC; Lee JJY; Fong V; Juraschka K; Przelicki D; Michealraj A; Skowron P; Luu B; Suzuki H; Morrissy AS; Cavalli FMG; Garzia L; Daniels C; Wu X; Qazi MA; Singh SK; Chan JA; Marra MA; Malkin D; Dirks P; Heisler L; Pugh T; Ng K; Notta F; Thompson EM; Kleinman CL; Joyner AL; Jabado N; Stein L; Taylor MD
Nature; 2019 Aug; 572(7767):67-73. PubMed ID: 31043743
[TBL] [Abstract][Full Text] [Related]
18. Molecular Subgrouping of Medulloblastoma: Impact Upon Research and Clinical Practice.
Gupta T; Shirsat N; Jalali R
Curr Pediatr Rev; 2015; 11(2):106-19. PubMed ID: 26133181
[TBL] [Abstract][Full Text] [Related]
19. Intertumoral and intratumoral heterogeneity as a barrier for effective treatment of medulloblastoma.
Wang X; Ramaswamy V; Remke M; Mack SC; Dubuc AM; Northcott PA; Taylor MD
Neurosurgery; 2013 Aug; 60 Suppl 1():57-63. PubMed ID: 23839353
[No Abstract] [Full Text] [Related]
20. Reproducibility of the NanoString 22-gene molecular subgroup assay for improved prognostic prediction of medulloblastoma.
Leal LF; Evangelista AF; de Paula FE; Caravina Almeida G; Carloni AC; Saggioro F; Stavale JN; Malheiros SMF; Mançano B; de Oliveira MA; Luu B; Neder L; Taylor MD; Reis RM
Neuropathology; 2018 Oct; 38(5):475-483. PubMed ID: 30155928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
